A citation-based method for searching scientific literature

J L Bernstein, S Teraoka, M C Southey, M A Jenkins, I L Andrulis, J A Knight, E M John, R Lapinski, A L Wolitzer, A S Whittemore, D West, D Seminara, E R Olson, A B Spurdle, G Chenevix-Trench, G G Giles, J L Hopper, P Concannon. Hum Mutat 2006
Times Cited: 66







List of co-cited articles
564 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006
469
54

Dominant negative ATM mutations in breast cancer families.
Georgia Chenevix-Trench, Amanda B Spurdle, Magtouf Gatei, Helena Kelly, Anna Marsh, Xiaoqing Chen, Karen Donn, Margaret Cummings, Dale Nyholt, Mark A Jenkins,[...]. J Natl Cancer Inst 2002
179
39

Rare variants in the ATM gene and risk of breast cancer.
David E Goldgar, Sue Healey, James G Dowty, Leonard Da Silva, Xiaoqing Chen, Amanda B Spurdle, Mary Beth Terry, Mary J Daly, Saundra M Buys, Melissa C Southey,[...]. Breast Cancer Res 2011
126
39

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
321
33

Breast and other cancers in families with ataxia-telangiectasia.
M Swift, P J Reitnauer, D Morrell, C L Chase. N Engl J Med 1987
581
31

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
491
30

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Sean V Tavtigian, Peter J Oefner, Davit Babikyan, Anne Hartmann, Sue Healey, Florence Le Calvez-Kelm, Fabienne Lesueur, Graham B Byrnes, Shu-Chun Chuang, Nathalie Forey,[...]. Am J Hum Genet 2009
119
27

Incidence of cancer in 161 families affected by ataxia-telangiectasia.
M Swift, D Morrell, R B Massey, C L Chase. N Engl J Med 1991
719
24

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
T Stankovic, A M Kidd, A Sutcliffe, G M McGuire, P Robinson, P Weber, T Bedenham, A R Bradwell, D F Easton, G G Lennox,[...]. Am J Hum Genet 1998
290
22


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
21

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
477
21

Heterozygous ATM mutations do not contribute to early onset of breast cancer.
M G FitzGerald, J M Bean, S R Hegde, H Unsal, D J MacDonald, D P Harkin, D M Finkelstein, K J Isselbacher, D A Haber. Nat Genet 1997
263
19

A single ataxia telangiectasia gene with a product similar to PI-3 kinase.
K Savitsky, A Bar-Shira, S Gilad, G Rotman, Y Ziv, L Vanagaite, D A Tagle, S Smith, T Uziel, S Sfez,[...]. Science 1995
18

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
A Broeks, J H Urbanus, A N Floore, E C Dahler, J G Klijn, E J Rutgers, P Devilee, N S Russell, F E van Leeuwen, L J van 't Veer. Am J Hum Genet 2000
167
18

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
652
18

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
J L Bernstein, L Bernstein, W D Thompson, C F Lynch, K E Malone, S L Teitelbaum, J H Olsen, H Anton-Culver, J D Boice, B S Rosenstein,[...]. Br J Cancer 2003
40
27

Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
T Dörk, R Bendix, M Bremer, D Rades, K Klöpper, M Nicke, B Skawran, A Hector, P Yamini, D Steinmann,[...]. Cancer Res 2001
120
16

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
490
16


Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
770
15

The incidence and gene frequency of ataxia-telangiectasia in the United States.
M Swift, D Morrell, E Cromartie, A R Chamberlin, M H Skolnick, D T Bishop. Am J Hum Genet 1986
281
15

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
273
15

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
J H Olsen, J M Hahnemann, A L Børresen-Dale, K Brøndum-Nielsen, L Hammarström, R Kleinerman, H Kääriäinen, T Lönnqvist, R Sankila, N Seersholm,[...]. J Natl Cancer Inst 2001
161
13

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
N Janin, N Andrieu, K Ossian, A Laugé, M F Croquette, C Griscelli, M Debré, B Bressac-de-Paillerets, A Aurias, D Stoppa-Lyonnet. Br J Cancer 1999
82
13


Contributions of ATM mutations to familial breast and ovarian cancer.
Yvonne R Thorstenson, Adriane Roxas, Regina Kroiss, Mark A Jenkins, Kristine M Yu, Thomas Bachrich, Daniela Muhr, Tierney L Wayne, Gilbert Chu, Ronald W Davis,[...]. Cancer Res 2003
113
13

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
13

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
13

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Patrick Concannon, Robert W Haile, Anne-Lise Børresen-Dale, Barry S Rosenstein, Richard A Gatti, Sharon N Teraoka, T Anh Diep, Laila Jansen, David P Atencio, Bryan Langholz,[...]. Cancer Res 2008
35
25

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
232
13

A PALB2 mutation associated with high risk of breast cancer.
Melissa C Southey, Zhi L Teo, James G Dowty, Fabrice A Odefrey, Daniel J Park, Marc Tischkowitz, Nelly Sabbaghian, Carmel Apicella, Graham B Byrnes, Ingrid Winship,[...]. Breast Cancer Res 2010
85
13

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
305
13

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
201
13

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
H M Inskip, L J Kinlen, A M Taylor, C G Woods, C F Arlett. Br J Cancer 1999
83
12

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.
J H Olsen, J M D Hahnemann, A-L Børresen-Dale, S Tretli, R Kleinerman, R Sankila, L Hammarström, T E Robsahm, H Kääriäinen, A Bregård,[...]. Br J Cancer 2005
29
27

Two ATM variants and breast cancer risk.
Deborah Thompson, Antonis C Antoniou, Mark Jenkins, Anna Marsh, Xiaoqing Chen, Tierney Wayne, Andrea Tesoriero, Roger Milne, Amanda Spurdle, Yvonne Thorstenson,[...]. Hum Mutat 2005
27
29

Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Csilla I Szabo, Mieke Schutte, Annegien Broeks, Jeanine J Houwing-Duistermaat, Yvonne R Thorstenson, Francine Durocher, Rogier A Oldenburg, Marijke Wasielewski, Fabrice Odefrey, Deborah Thompson,[...]. Cancer Res 2004
40
20

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12



A recurrent mutation in PALB2 in Finnish cancer families.
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko,[...]. Nature 2007
311
12

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
Monica Marabelli, Su-Chun Cheng, Giovanni Parmigiani. Genet Epidemiol 2016
48
16

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.
Graham J Mann, Heather Thorne, Rosemary L Balleine, Phyllis N Butow, Christine L Clarke, Edward Edkins, Gerda M Evans, Sián Fereday, Eric Haan, Michael Gattas,[...]. Breast Cancer Res 2006
121
10

Malignant neoplasms in the families of patients with ataxia-telangiectasia.
M Swift, L Sholman, M Perry, C Chase. Cancer Res 1976
253
10

Cancer risk in heterozygotes for ataxia-telangiectasia.
B Geoffroy-Perez, N Janin, K Ossian, A Laugé, M F Croquette, C Griscelli, M Debré, B Bressac-de-Paillerets, A Aurias, D Stoppa-Lyonnet,[...]. Int J Cancer 2001
93
10

The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
J Chen, G G Birkholtz, P Lindblom, C Rubio, A Lindblom. Cancer Res 1998
85
10

The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation.
I Vorechovský, D Rasio, L Luo, C Monaco, L Hammarström, A D Webster, J Zaloudik, G Barbanti-Brodani, M James, G Russo. Cancer Res 1996
148
10

The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
Philip Bretsky, Christopher A Haiman, Shlomit Gilad, Joachim Yahalom, Avital Grossman, Shoshana Paglin, David Van Den Berg, Laurence N Kolonel, Rami Skaliter, Brian E Henderson. Cancer Epidemiol Biomarkers Prev 2003
42
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.